You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 3, March 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Penicillin in Sickle Cell Anemia

A Panacea for the Lost Spleen?

Darleen Powars, MD; Gary Overturf, MD

Am J Dis Child. 1987;141(3):250-252.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Ideally, antibiotic prophylaxis should prevent disease caused by virulent organisms in immunodeficient patients. Antibiotics may interrupt the initial nasopharyngeal colonization or prevent the primary bacteremia and ensuing metastatic infection. The predilection for severe and frequent pneumococcal infections in children with sickle cell anemia, the critical link to the early loss of splenic function, and the age-adjusted prevalence rates have been amply emphasized by previous investigations.1-3 Unaccountably, the risk of pneumococcal septicemia is much higher in the young child with sickle cell anemia than in children of comparable age who have undergone simple splenectomy. In children with sickle cell anemia, the risk of pneumococcal septicemia is highest before the age of 3 years. Unfortunately, this is the same age at which multivalent pneumococcal vaccines do not reliably induce protective antibodies. Furthermore, in young children, it is not clear whether vaccines alter the nasopharyngeal carrier rate.3 Thus, the pneumococcal vaccines . . . [Full Text PDF of this Article]


Author Affiliations

Department of Pediatrics Division of Hematology/Oncology University of Southern California School of Medicine 1200 N State St Los Angeles, CA 90033; Department of Pediatrics University of California at Los Angeles Olive View Medical Center 7533 Van Nuys Blvd Suite 301 S Tower Van Nuys, CA 91405



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.